Verdict: Side-by-side breakdown using the Bull Rankings model. BTSG scored 63.1, DOCS scored 70.8 — DOCS leads.
Compare another set
BTSG
BrightSpring Health Services, Inc.
Health Information Services · Quality-Growth
63.1
$63.74 · $12.6B
fundamentals as of
Score gap
7.7
DOCS leads
DOCS
Doximity, Inc.
Health Information Services · Quality-Growth
70.8
$30.50 · $5.4B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
CheapestDOCS35.9x
Fastest growthBTSG+28.2%
Strongest balance sheetDOCS0.01
Highest qualityDOCS88 / 100
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
BTSG
stronger →← stronger
DOCS
49
Qualityreturns · margins · balance sheet
88
95
Growthrevenue & earnings expansion
70
54
Valuevaluation vs sector peers
58
DOCS is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
BTSG
DOCS
$402mC
FCF
$297mC
+28.2%A-
Rev
+13.1%B+
1.16C
D/E
0.01A-
56.4xC
P/E
35.9xC+
2.24C
PEG
0.59A-
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
BTSG
DOCS
120% above
Price vs fair valuelower is cheaper
18% above
~38%/yr
Growth the price impliesyr-1 FCF growth, fading to 4% · lower = less priced in
~13%/yr
-65%
1-yr DCF upside
-25%
-55%
5-yr DCF upside
-15%
-36%
10-yr DCF upside
0%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
BTSG
Why this score
Diluting shareholders
Short track record
DOCS
Why this score
Durable high returns
The companies
BTSGBrightSpring Health Services, Inc.
Health Information Services · $63.74 · beta 1.88
Why now
Health Information Services · market cap $12.6b. 14% off the 52-week high of $73.75. Revenue growing +28% — in hypergrowth territory. 17 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $78.94 (implying +24% upside).
Moat
ROE 13% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. FCF converts 162% of net income — earnings translate cleanly into cash.
Risk
Trailing P/E 56.4x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Beta 1.88 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return. Net margin 2.5% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
DOCSDoximity, Inc.
Health Information Services · $30.50 · beta 1.22
Why now
Health Information Services · market cap $5.4b. Down 58% from 52-week high of $72.24 — deep drawdown territory. Revenue growing +13%, comfortably above the S&P median. PEG 0.59 — paying under fair value for the growth rate. 18 sell-side analysts rate this a Hold with a mean 1-yr target of $29.67 (implying -3% upside).
Moat
Net margin 25% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 17% is above 15% — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 178% of net income — earnings translate cleanly into cash.
Risk
Down 58% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 36x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where BTSG and DOCS diverge
On the headline score the gap is 7.7 points in favor of DOCS. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.
QualityBTSG 48.6 · DOCS 87.5DOCS +38.9
GrowthBTSG 95.2 · DOCS 69.7BTSG +25.5
ValueBTSG 54.2 · DOCS 58.2DOCS +4.0
Pillars run 0–100. Value is judged against each company's own sector, so a Value score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.
Common questions
Is DOCS or BTSG the better stock?
DOCS scores higher: DOCS 70.8, BTSG 63.1 out of 100 on the Bull Rankings quality-growth score, which blends business quality, growth and valuation into one number. A higher score means a stronger business at a more reasonable price — it is not a price target or a recommendation.
Where do DOCS and BTSG differ most?
The widest gap is quality, where DOCS leads by 39 points on the 0–100 pillar scale. Neither name sweeps: they trade the lead across the three pillars, so the comparison is a trade-off rather than one being better on every measure.
How are DOCS and BTSG scored?
Each carries the same 0–100 quality-growth score used everywhere on the site, built from three pillars — quality (profitability and returns on capital), growth (revenue and earnings), and value (what you pay for them) — combined as a geometric mean, so a weak pillar cannot be papered over by a strong one.
How current is this comparison?
The whole universe is re-scored every trading day after the US market close, so the scores and fundamentals here reflect the latest published edition.